Low-dose radiation plus immunotherapy shows promise for liver-limited colorectal cancer
NCT ID NCT06848465
First seen Apr 03, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This early-phase trial tests whether adding low-dose radiotherapy to standard immunotherapy and chemotherapy is safe for people with colorectal cancer that has spread only to the liver. About 9 to 18 adults who have not had prior treatment will receive the combination. The main goal is to check for side effects, while also measuring how well the tumors shrink and how long people live without the cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Army Medical Center
RECRUITINGChongqing, Chongqing Municipality, 400042, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Daping Hospital, Army Medical University
ACTIVE_NOT_RECRUITINGChongqing, Chongqing Municipality, 400042, China
Conditions
Explore the condition pages connected to this study.